EurekAlert! -
15 Oct 2020 06:00
(H. Lee Moffitt Cancer Center & Research Institute) In a new article published in the journal Nature Communications, Moffitt Cancer Center researchers describe how the protein TAp63 controls levels of RNA molecules, which subsequently connects the activities of p53 and AKT to promote disease progression.
Share this Article